Macular Degeneration Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People of any age who have high short-sightedness (nearsightedness), meaning their prescription is -6 or stronger
Who may not be able to join:
- People who have a history of other eye diseases, or conditions affecting the rest of the body that may impact blood flow to the eyes
- People who have had previous eye surgery or an injury to the eye
- People who have certain types of damage to the central part of the retina (the back of the eye) related to their short-sightedness, such as scarring, abnormal membrane growth, fluid buildup, holes, cracks, abnormal blood vessel growth, or tissue loss (confirm with trial site if unsure whether your specific condition applies)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Adham Salah Mohammed, lecturer, Sohag University
Phone: 00201096507733
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Outcome of evaluation of vascular density in high myopes
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.